2018 publications

Murthy SE, Chatterjee F, Crook A, Dawson R, Mendel C, Murphy ME, Murray SR, Nunn AJ, Phillips PPJ, Singh KP, McHugh TD, Gillespie SH; REMoxTB Consortium. Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis. BMC Med. 2018 May 21;16(1):73. doi: 10.1186/s12916-018-1053-3

Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A. Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16.

Uddin F, McHugh TD, Roulston K, Platt G, Khan TA, Sohail M. Detection of carbapenemases, AmpC and ESBL genes in Acinetobacter isolates from ICUs by DNA microarray. J Microbiol Methods. 2018 Dec;155:19-23. doi: 10.1016/j.mimet.2018.11.004. Epub 2018 Nov 10.

Murphy ME, Wills GH, Murthy S, Louw C, Bateson ALC, Hunt RD, McHugh TD, Nunn AJ, Meredith SK, Mendel CM, Spigelman M, Crook AM, Gillespie SH; REMoxTB consortium. Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study. BMC Med. 2018 Oct 17;16(1):189. doi: 10.1186/s12916-018-1169-5

Vanstone GL, Wey E, Mack D, Smith ER, Balakrishnan I. Evaluation of the EntericBio CPE assay for the detection of carbapenemase-producing organisms. J Med Microbiol. 2018 Dec;67(12):1728-1730. doi: 10.1099/jmm.0.000851. Epub 2018 Oct 15.

Uddin F, Roulston K, McHugh TD, Khan TA, Sohail M. Bacteremia in a human caused by an XDR strain of Pseudomonas fulva. J Infect Dev Ctries. 2018 Jul 31;12(7):597-599. doi: 10.3855/jidc.10326

Tweed CD, Crook AM, Amukoye EI, Dawson R, Diacon AH, Hanekom M, McHugh TD, Mendel CM, Meredith SK, Murphy ME, Murthy SE, Nunn AJ, Phillips PPJ, Singh KP, Spigelman M, Wills GH, Gillespie SH. Toxicity associated with tuberculosis chemotherapy in the REMoxTB study. BMC Infect Dis. 2018 Jul 11;18(1):317. doi: 10.1186/s12879-018-3230-6

Aisyah DN, Shallcross L, Hayward A, Aldridge RW, Hemming S, Yates S, Ferenando G, Possas L, Garber E, Watson JM, Geretti AM, McHugh TD, Lipman M, Story A. Hepatitis C among vulnerable populations: A seroprevalence study of homeless, people who inject drugs and prisoners in London. J Viral Hepat. 2018 Nov;25(11):1260-1269. doi: 10.1111/jvh.12936. Epub 2018 Jun 20. .

Doyle RM, Burgess C, Williams R, Gorton R, Booth H, Brown J, Bryant JM, Chan J, Creer D, Holdstock J, Kunst H, Lozewicz S, Platt G, Romero EY, Speight G, Tiberi S, Abubakar I, Lipman M, McHugh TD, Breuer J. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing. J Clin Microbiol. 2018 Jul 26;56(8):e00666-18. doi: 10.1128/JCM.00666-18

Murthy SE, Chatterjee F, Crook A, Dawson R, Mendel C, Murphy ME, Murray SR, Nunn AJ, Phillips PPJ, Singh KP, McHugh TD, Gillespie SH; REMoxTB Consortium. Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis. BMC Med. 2018 May 21;16(1):73. doi: 10.1186/s12916-018-1053-3.

Camon S, Quiros C, Saubi N, Moreno A, Marcos MA, Eto Y, Rofael S, Monclus E, Brown J, McHugh TD, Mallolas J, Perello R. Full blood count values as a predictor of poor outcome of pneumonia among HIV-infected patients. BMC Infect Dis. 2018 Apr 19;18(1):189. doi: 10.1186/s12879-018-3090-0

Schwenk S, Moores A, Nobeli I, McHugh TD, Arnvig KB. Cell-wall synthesis and ribosome maturation are co-regulated by an RNA switch in Mycobacterium tuberculosis. Nucleic Acids Res. 2018 Jun 20;46(11):5837-5849. doi: 10.1093/nar/gky226

Ghoma Linguissi LS, Lucaccioni V, Bates M, Zumla A, Ntoumi F. Achieving sustainable development goals for HIV/AIDS in the Republic of the Congo - Progress, obstacles and challenges in HIV/AIDS health services. Int J Infect Dis. 2018 Dec;77:107-112. doi: 10.1016/j.ijid.2018.10.009. Epub 2018 Oct 17.

Zumla A, Abubakar I. Improving access to multi-drug resistant tuberculosis diagnostic and health services for refugees and migrants. BMC Med. 2018 Nov 30;16(1):221. doi: 10.1186/s12916-018-1218-0

Tembo J, Chandwe K, Kabwe M, Chilufya M, Ciccone O, Mpabalwani E, Ablashi D, Zumla A, Chen T, Bates M. Children infected by human herpesvirus 6B with febrile seizures are more likely to develop febrile status epilepticus: A case-control study in a referral hospital in Zambia. J Med Virol. 2018 Nov;90(11):1757-1764. doi: 10.1002/jmv.25269 Epub 2018 Aug 13.

Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018 Aug;18(8):e217-e227. doi: 10.1016/S1473-3099(18)30127-0. Epub 2018 Apr 18.

White PL, Price JS, Posso RB, Barnes RA. An evaluation of the performance of the Dynamiker® Fungus (1-3)-β-D-Glucan Assay to assist in the diagnosis of invasive aspergillosis, invasive candidiasis and Pneumocystis pneumonia. Med Mycol. 2017 Nov 1;55(8):843-850. doi: 10.1093/mmy/myx004

Herbert N, Masham BS, Suttie BA, Sharma V, Albani S, Domenti O, Flurry R, Oliver M, Zumla A. Advancing political will to end the tuberculosis epidemic. Lancet Infect Dis. 2018 Jul;18(7):711-712. doi: 10.1016/S1473-3099(17)30679-5. Epub 2017 Nov 15.

Tweed CD, Wills GH, Crook AM, Dawson R, Diacon AH, Louw CE, McHugh TD, Mendel C, Meredith S, Mohapi L, Murphy ME, Murray S, Murthy S, Nunn AJ, Phillips PPJ, Singh K, Spigelman M, Gillespie SH. Liver toxicity associated with tuberculosis chemotherapy in the REMoxTB study. BMC Med. 2018 Mar 28;16(1):46. doi: 10.1186/s12916-018-1033-7

Herbert N, Sharma V, Masham BS, Sheehan BS, Hauser J, Zumla A. Concrete action now: UN High-Level Meeting on Tuberculosis. Lancet Infect Dis. 2018 Jul;18(7):709-710. doi: 10.1016/S1473-3099(18)30171-3. Epub 2018 Mar 23.

Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, Mfinanga S, Kapata N, Mwaba P, McHugh TD, Ippolito G, Migliori GB, Maeurer MJ, Zumla A. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018 Jul;18(7):e183-e198. doi: 10.1016/S1473-3099(18)30110-5. Epub 2018 Mar 23. Erratum in: Lancet Infect Dis. 2018 Apr 27;

Walzl G, McNerney R, du Plessis N, Bates M, McHugh TD, Chegou NN, Zumla A. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis. 2018 Jul;18(7):e199-e210. doi: 10.1016/S1473-3099(18)30111-7. Epub 2018 Mar 23.

Bowman C, Davies HG, Wey E. New drug therapies for the management of drug-resistant tuberculosis. Br J Hosp Med (Lond). 2018 Jun 2;79(6):C90-C92. doi: 10.12968/hmed.2018.79.6.C90

Mer M, Zumla A, Dünser MW. Limiting consumption in tuberculosis: current concepts in anti-tuberculosis treatment in the critically ill patient. Intensive Care Med. 2018 Dec;44(12):2229-2231. doi: 10.1007/s00134-018-5161-5. Epub 2018 May 11.

Gautret P, Okolo S, Elachola H, Zumla A, Memish ZA. Mitigating the risks of global spread of Lassa fever at the 2018 Hajj pilgrimage. Travel Med Infect Dis. 2018 May-Jun;23:99-100. doi: 10.1016/j.tmaid.2018.04.016. Epub 2018 Apr 27

Zumla A, Azhar EI, Hui DS, Shafi S, Petersen E, Memish ZA. Global spread of antibiotic-resistant bacteria and mass-gathering religious events. Lancet Infect Dis. 2018 May;18(5):488-490. doi: 10.1016/S1473-3099(18)30242-1

Schuenemann VJ, Avanzi C, Krause-Kyora B, Seitz A, Herbig A, Inskip S, Bonazzi M, Reiter E, Urban C, Dangvard Pedersen D, Taylor GM, Singh P, Stewart GR, Velemínský P, Likovsky J, Marcsik A, Molnár E, Pálfi G, Mariotti V, Riga A, Belcastro MG, Boldsen JL, Nebel A, Mays S, Donoghue HD, Zakrzewski S, Benjak A, Nieselt K, Cole ST, Krause J. Ancient genomes reveal a high diversity of Mycobacterium leprae in medieval Europe. PLoS Pathog. 2018 May 10;14(5):e1006997. doi: 10.1371/journal.ppat.1006997

Silva DR, Mello FCQ, Kritski A, Dalcolmo M, Zumla A, Migliori GB. Tuberculosis series. J Bras Pneumol. 2018 Apr;44(2):71-72. doi: 10.1590/s1806-37562018000020001

Silva DR, Dalcolmo M, Tiberi S, Arbex MA, Munoz-Torrico M, Duarte R, D'Ambrosio L, Visca D, Rendon A, Gaga M, Zumla A, Migliori GB. New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis. J Bras Pneumol. 2018 Apr;44(2):153-160. doi: 10.1590/s1806-37562017000000436

Floyd K, Glaziou P, Zumla A, Raviglione M. The global tuberculosis epidemic and progress in care, prevention, and research: an overview in year 3 of the End TB era. Lancet Respir Med. 2018 Apr;6(4):299-314. doi: 10.1016/S2213-2600(18)30057-2

Rao M, Valentini D, Zumla A, Maeurer M. Evaluation of the efficacy of valproic acid and suberoylanilide hydroxamic acid (vorinostat) in enhancing the effects of first-line tuberculosis drugs against intracellular Mycobacterium tuberculosis. Int J Infect Dis. 2018 Apr;69:78-84. doi: 10.1016/j.ijid.2018.02.021. Epub 2018 Mar 2.

Tembo J, Moraleda C, Rojo P, Zumla A, Bates M. Urgent need for multi-site controlled trials for CMV pneumonia treatment in African children. Int J Tuberc Lung Dis. 2018 Apr 1;22(4):469-470. doi: 10.5588/ijtld.17.0847

Lienhardt C, Zumla A, Gebreselassie N, Frick M, Gray G, Kasaeva T, Raviglione M. Tuberculosis research and development: seeding the future. Lancet Respir Med. 2018 Apr;6(4):242-244. doi: 10.1016/S2213-2600(18)30050-X

Maeurer M, Rao M, Zumla A. B cells or T cells in TB: a continuing conundrum. Lancet Respir Med. 2018 Apr;6(4):237-238. doi: 10.1016/S2213-2600(18)30080-8

Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D, Mwaba P, Vilaplana C, Dar O, Bates M, Corrah T, Rao M, Kapata N, Azhar EI, Memish ZA, Mfinanga S, Aseffa A, Ippolito G, Migliori GB, Zumla A. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB". Int J Infect Dis. 2018 Mar;68:122-124. doi: 10.1016/j.ijid.2018.03.002. Epub 2018 Mar 22.

Vanstone GL, Woodhead S, Roulston K, Sharma H, Wey E, Smith ER, Mack D, Balakrishnan I. Improving the detection of carbapenemase-producing organisms (CPO) in a low-prevalence setting: evaluation of four commercial methods and implementation of an algorithm of testing. J Med Microbiol. 2018 Feb;67(2):208-214. doi: 10.1099/jmm.0.000674.

Danquah CA, Kakagianni E, Khondkar P, Maitra A, Rahman M, Evangelopoulos D, McHugh TD, Stapleton P, Malkinson J, Bhakta S, Gibbons S. Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition. Sci Rep. 2018 Jan 18;8(1):1150. doi: 10.1038/s41598-017-18948-w

Lanini S, Portella G, Vairo F, Kobinger GP, Pesenti A, Langer M, Kabia S, Brogiato G, Amone J, Castilletti C, Miccio R, Capobianchi MR, Strada G, Zumla A, Di Caro A, Ippolito G; INMI-EMERGENCY EBOV Sierra Leone Study Group. Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study. Clin Infect Dis. 2018 Jan 6;66(1):36-44. doi: 10.1093/cid/cix704